Women with high leptin levels, lower circulating levels of adiponectin in serum due to obesity, hyperinsulinaemia, and high leptin/adiponectin ratio have the highest risk of developing endometrial cancer [186]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.